Efficient biosynthesis of antitumor ganoderic acid HLDOA using a dual tunable system for optimizing the expression of CYP5150L8 and a Ganoderma P450 reductase
- 26 August 2019
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 116 (12) , 3301-3311
Abstract
Ganoderic acid 3‐hydroxy‐lanosta‐8,24‐dien‐26‐oic acid (GA‐HLDOA), an antitumor triterpenoid from the traditional Chinese medicinal higher fungus Ganoderma lucidum, is considered as a key precursor for biosynthesizing other ganoderic acids (GAs) with superior antitumor activities. Our previous study identified CYP5150L8 from G. lucidum as a lanosterol oxidase, and achieved heterologous biosynthesis of GA‐HLDOA in Saccharomyces cerevisiae. However, low production of GA‐HLDOA in either G. lucidum or heterologous host hindered its further investigation and application. In this study, we constructed a dual tunable system for balancing the expression of CYP5150L8 and a Ganoderma P450 reductase iGLCPR, and performed a comprehensive optimization of CYP5150L8 expression, iGLCPR expression, and glycerol usage. Then, we investigated the fermentation behavior of the best strain in optimized condition in flask and achieved 154.45 mg/L GA‐HLDOA production, which was 10.7‐fold higher compared with previous report. This study may facilitate the wide‐spread application of GA‐HLDOA and the discovery of unknown cytochrome P450s in downstream GAs biosynthesis.Keywords
Funding Information
- National Natural Science Foundation of China (31600071)
- Natural Science Foundation of Shanghai Municipality (17ZR1448900, 18ZR1420300)
This publication has 47 references indexed in Scilit:
- Genome sequence of the model medicinal mushroom Ganoderma lucidumNature Communications, 2012
- Linking Genotype and Phenotype of Saccharomyces cerevisiae Strains Reveals Metabolic Engineering Targets and Leads to Triterpene Hyper-ProducersPLOS ONE, 2011
- Cytochrome P450 Reductase: A Harbinger of Diffusible Reduced Oxygen SpeciesPLOS ONE, 2010
- New cytochrome P450 mechanisms: implications for understanding molecular basis for drug toxicity at the level of the cytochromeExpert Opinion on Drug Metabolism & Toxicology, 2009
- DNA assembler, an in vivo genetic method for rapid construction of biochemical pathwaysNucleic Acids Research, 2008
- High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG methodNature Protocols, 2007
- Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cellsLife Sciences, 2006
- Electron Transfer in Flavocytochrome P450 BM3: Kinetics of Flavin Reduction and Oxidation, the Role of Cysteine 999, and Relationships with Mammalian Cytochrome P450 ReductaseBiochemistry, 2003
- A Self‐Sufficient Peroxide‐Driven Hydroxylation BiocatalystAngewandte Chemie International Edition, 2003
- P450 in biotechnology: zinc driven ω-hydroxylation of p-nitrophenoxydodecanoic acid using P450 BM-3 F87A as a catalystJournal of Biotechnology, 2000